Ligand Enters Into OmniAb® Platform License Agreement With ABBA Therapeutics

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. BILL
5. ADI
6. MRK
7. MRNA
8. WMT
9. ROST
10. NTES

Go back to Ligand Enters Into OmniAb® Platform License Agreement With ABBA Therapeutics
LIGAND PHARMA (NASDAQ: LGND) Delayed: 287.38 -3.33 (1.15%)
Previous Close $290.71    52 Week High $139.79 
Open $289.11    52 Week Low $82.07 
Day High $293.37    P/E 668.33 
Day Low $284.87    EPS $0.43 
Volume 107,782